Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20140503017537N5Phase 3Completed
Phase 3 trial of tranexamic acid in alveolar osteitis (AO), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Incidence of dry socket (alveolar osteitis). Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20140503017537N5.